Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells

转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化

基本信息

  • 批准号:
    10688201
  • 负责人:
  • 金额:
    $ 48.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT During the past decades, studies of heart development have been mainly focused on conserved gene regulatory mechanisms, which control various aspects of cardiogenesis across multiple species from drosophila to mouse. These conserved gene programs include cardiac transcriptional factors (such as Nkx2.5, Isl1, Tbx20), microRNAs, and epigenetic regulators. Despite the high evolutionary conservation of cardiogenesis, the human heart exhibits unique properties, including distinctive morphogenesis and electrophysiological properties. These species-specific differences suggest the existence of novel genetic programs in each species. As the limitation of experimental setting, it remains unclear the mechanisms that regulate unique aspects of human cardiogenesis, and how human-specific mechanisms interact with conserved gene programs to fine-tune human heart development. Recently, accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) play important roles in cell fate specification and organogenesis, including the heart. LncRNAs are greater than 200bp non-coding transcripts, which account for >40% of human transcriptome. Many lncRNAs are tissue-specific and species-specific. Recently, we identified a novel human-specific lncRNA, named Heart Brake LncRNA1 (HBL1) (Dev. Cell. 2017, 4:333-8). HBL1 is highly expressed in both cytoplasm and nucleus of human induced pluripotent stem cells (hiPSCs). Cytosolic HBL1 modulates cardiomyocyte (CM) development from hiPSCs by counteracting microRNA1 (MIR1). Pluripotency marker gene SOX2 activates HBL1 transcription. In this proposal, we will analyze further, a novel mechanism of nuclear HBL1 in initiating the cardiac gene-expressing program via interacting with polycomb repressive complex 2 (PRC2). Additionally, we will test a hypothesis that HBL1 adds a new layer of human- specific regulatory mechanism on top of a conserved cardiogenic axis. All together, the central hypothesis is that transcriptional factor SOX2, lncRNA HBL1, microRNA-1 and PRC2 complex composite a whole network to control human cardiogenesis from pluripotent stem cells.
项目总结/文摘

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism.
  • DOI:
    10.1038/s41556-023-01162-4
  • 发表时间:
    2023-07
  • 期刊:
  • 影响因子:
    21.3
  • 作者:
  • 通讯作者:
Multidimensional Mechanistic Spectrum of Long Non-coding RNAs in Heart Development and Disease.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lei Yang其他文献

Lei Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lei Yang', 18)}}的其他基金

Deciphering a Novel LncRNA-mediated Lipid Droplet Transport System in Human Heart
破译人类心脏中新型 LncRNA 介导的脂滴转运系统
  • 批准号:
    10640148
  • 财政年份:
    2022
  • 资助金额:
    $ 48.86万
  • 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
  • 批准号:
    9796511
  • 财政年份:
    2019
  • 资助金额:
    $ 48.86万
  • 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
  • 批准号:
    10242624
  • 财政年份:
    2019
  • 资助金额:
    $ 48.86万
  • 项目类别:
Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells
转录因子 SOX2、LncRNA HBL1、microRNA1 和 PRC2 表观遗传复合物组成一个网络来协调人类多能干细胞的心脏分化
  • 批准号:
    10463693
  • 财政年份:
    2019
  • 资助金额:
    $ 48.86万
  • 项目类别:
Embryonic stem cell/induced Pluripotent stem cell growth and gene editing core
胚胎干细胞/诱导多能干细胞生长和基因编辑核心
  • 批准号:
    10495947
  • 财政年份:
    2017
  • 资助金额:
    $ 48.86万
  • 项目类别:
Toward Regeneration of Whole Bioartificial Human Heart
走向整个生物人工心脏的再生
  • 批准号:
    8749862
  • 财政年份:
    2014
  • 资助金额:
    $ 48.86万
  • 项目类别:

相似海外基金

Integrating CRISPR-Cas Technology into Organic Electronics for Rapid Point-of-Care Genotyping
将 CRISPR-Cas 技术集成到有机电子器件中以实现快速护理点基因分型
  • 批准号:
    BB/X003442/1
  • 财政年份:
    2023
  • 资助金额:
    $ 48.86万
  • 项目类别:
    Research Grant
Platform for CRISPR/Cas technology and AAV atherosclerosis model (S03)
CRISPR/Cas技术和AAV动脉粥样硬化模型平台(S03)
  • 批准号:
    408096640
  • 财政年份:
    2018
  • 资助金额:
    $ 48.86万
  • 项目类别:
    Collaborative Research Centres
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了